Product Information
ERYTHROMYCIN-BENZOYL GEL is a generic product labeled by Oceanside Pharmaceuticals, priced at $1.5405 per GM under NDC 68682090023. Its NADAC has been published 502 times since Feb 24, 2016.
FDA first approved this application on Oct 26, 1984. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Oceanside PharmaceuticalsNDC
68682090023
Classification
Generic
Dosage Form
KIT
Effective Date
9/17/2025
Approval Type
Authorized Generic (NDA)
FDA Application
NDA050557FDA Approved
10/26/1984
TE Code
AB
On Market Since
10/26/1984
Price Statistics
The NADAC for ERYTHROMYCIN-BENZOYL GEL has been published 502 times since Feb 24, 2016, and over the history we have for it it has declined 75.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5405 per GM |
|---|---|
| All-time high | $6.6520 (May 11, 2016) |
| All-time low | $1.3020 (May 22, 2024) |
| Median price | $2.7549 |
| Average price | $3.1624 |
| Largest weekly change | +77.0% (Jun 23, 2021) |
| Weeks tracked | 502 |
| Tracking since | Feb 24, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-2.5%
5Y
-35.7%
All
-75.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin and Benzoyl Peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN-BENZOYL GEL?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN-BENZOYL GEL, manufactured by Oceanside Pharmaceuticals, is $1.5405 per GM (NDC 68682090023), effective Oct 1, 2025.
How has the price of ERYTHROMYCIN-BENZOYL GEL changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN-BENZOYL GEL has declined 75.5%. It has been tracked across 502 weekly CMS publications since Feb 24, 2016.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN-BENZOYL GEL?
Since Feb 24, 2016, the NADAC for ERYTHROMYCIN-BENZOYL GEL has ranged from a low of $1.3020 (May 22, 2024) to a high of $6.6520 (May 11, 2016), with a median of $2.7549 per GM.
Are there cheaper alternatives to ERYTHROMYCIN-BENZOYL GEL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN-BENZOYL GEL, is $0.9375 per GM — about 39% below ERYTHROMYCIN-BENZOYL GEL.
Who manufactures ERYTHROMYCIN-BENZOYL GEL?
ERYTHROMYCIN-BENZOYL GEL (NDC 68682090023) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.